Towards a more cost-effective diabetes control in primary care: the EFFIMODI (EFFIcient MOnitoring of DIabetes) trial

Completed

• Conditions: Type 2 diabetes mellitus; Nutritional, Metabolic, Endocrine; Non-insulin-dependent diabetes mellitus

• Registration Number: ISRCTN93201802
• Lead Sponsor: niversity Medical Center Utrecht (UMCU) (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-07-14
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2250

Inclusion Criteria

1. People with DM2
2. Aged 40 - 80 years, either sex
3. Treated by their general practitioner

Exclusion Criteria

Contraindications for less frequent than three-monthly monitoring:
1. Duration of DM2 for less than one year
2. Insulin treatment
3. HbA1c greater than 7.5%
4. Systolic blood pressure greater than 145 mmHg
5. Total cholesterol greater than 5.2 mmol/

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current information as of 30/03/2010:<br>Percentage of people that remains under good cardiometabolic control, defined as having HbA1c less than or equal to 7.5% and systolic blood pressure less than or equal to 145 mmHg and total cholesterol less than or equal to 5.2 mmol/l. HbA1c, systolic blood pressure and total cholesterol will be collected from the general practitioners' Information System. <br><br>Initial information at time of registration:<br>Change in glycaemic control, expressed as the mean change in HbA1c percentage between baseline and follow-up. HbA1c will be collected from the general practitioners' Information System.